[Source: Daily Economic News]
Every article by reporter Song Sijian and every editorial article
July 2, by Sichuan University, Chengdu High-tech Under the guidance of the district management committee, the “World Biosafety and Frontier Medicine Summit Forum” co-sponsored by the Chinese People’s Life Safety Research Institute of West China Hospital of Sichuan University, the China Strategic Research Center of Peking University, and the China Society of Land Economics was held in Chengdu. 13 academicians and more than 150 experts and scholars from the medical field attended the meeting.
Li Weimin, Dean of West China Hospital, Sichuan University Photo source: Photo courtesy of the organizer
Daily The Economic News reporter noticed at the scene that Professor Li Weimin, President of West China Hospital of Sichuan University and Vice President of the Chinese Medical Association, said in his speech that the research on an innovative anti-pulmonary fibrosis Chinese medicine is progressing smoothly. He introduced that this innovative drug is a product with a new structure and mechanism, independent intellectual property rights and derived from traditional Chinese medicine, and its anti-pulmonary fibrosis effect is significantly better than that of the international first-line drug nintedanib. It is expected to become the “Huaxi business card” for Chinese medicine to go to the world.
Disclaimer: The copyright of this article belongs to the original author. If the source is wrong or your legal rights are violated, you can contact us by email, and we will deal with it in time. Email address: [email protected]